News
Center

Presentation at Society for Immunotherapy of Cancer Annual Meeting
Abstract Title: IMMUNOCERV, an ongoing Phase II trial combining PDS0101, an HPV-specific T cell immunotherapy, with chemotherapy and radiation for treatment of locally advanced cervical cancers
Abstract Number: 674
Presenting Author: Dr. Ann Klopp, The University of Texas MD Anderson Cancer Center